Insulin Resistance – References

Benjamin Bikman

Current: Professor, Department of Cell Biology and Physiology, Brigham Young University

Past: Duke-National University of Singapore Medical School

Professor Benjamin Bikman is a biomedical scientist with a focus on understanding and sharing the origins and effects of elevated

References

Insulin Resistance – References

  1. Araújo, J., et al. (2018). Prevalence of optimal metabolic health in American adults. Metabolic Syndrome and Related Disorders, 16(2), 62–68. PMID: 30484738.  
  2. CDC. (2022). National Diabetes Statistics Report.  
  3. ACOG. (2020). Gestational diabetes mellitus. Obstetrics & Gynecology, 135(2), e49–e65.  
  4. ADA. (2023). Statistics about diabetes. American Diabetes Association.  
  5. de la Monte, S. M. (2014). Type 3 diabetes is sporadic Alzheimer’s disease. European Neuropsychopharmacology, 24(12), 1954–1960.  
  6. Sakurai, M., et al. (2013). Prevalence of prediabetes in Japan. Journal of Diabetes Investigation, 4(2), 162–168.  
  7. Fryar, C. D., et al. (2021). Prevalence of obesity among adults, NHANES 1980–2018. NCHS Data Brief, No. 360.  
  8. Deputy, N. P., et al. (2018). Trends in gestational diabetes, 1990–2016. MMWR, 67(43), 1209–1213.  
  9. Wang, L., et al. (2021). Prevalence of prediabetes in China. JAMA Network Open, 4(6), e2111315.  
  10. Berenson, G. S., et al. (1998). Association between multiple cardiovascular risk factors and atherosclerosis in children. New England Journal of Medicine, 338(23), 1650–1656.  
  11. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature, 444(7121), 860–867.  
  12. Brownlee, M. (2005). The pathobiology of diabetic complications. Diabetes, 54(6), 1615–1625.  
  13. Catalano, P. M., et al. (2009). The hyperglycemia and adverse pregnancy outcome study. Diabetes Care, 32(6), 1026–1032.  
  14. Reaven, G. M. (2005). The insulin resistance syndrome. Endocrine Reviews, 26(5), 657–673.  
  15. Younossi, Z. M., et al. (2016). Global epidemiology of NAFLD. Hepatology, 64(1), 73–84.  
  16. Craft, S., et al. (2012). Insulin resistance and Alzheimer’s disease pathogenesis. Current Alzheimer Research, 9(1), 35–44.  
  17. Dunaif, A. (1997). Insulin resistance and PCOS. Endocrine Reviews, 18(6), 774–800.  
  18. Chen, J., et al. (2016). Insulin resistance and risk of chronic kidney disease. Kidney International, 89(5), 1070–1078.  
  19. Emerging Risk Factors Collaboration. (2011). Diabetes mellitus, fasting glucose, and risk of cause-specific death. New England Journal of Medicine, 364(9), 829–841.  
  20. Knowler, W. C., et al. (2002). Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393–403.  
  21. Koh, K. K., et al. (2010). Effects of statins on vascular function in patients with insulin resistance. Atherosclerosis, 211(2), 490–495.  
  22. USDA. (2020). Dietary Guidelines for Americans 2020–2025.  
  23. Shan, Z., et al. (2019). Trends in dietary carbohydrate, protein, and fat intake among US adults, 1999–2016. JAMA Network Open, 2(5), e1916014. PMID: 31206566.  
  24. Ludwig, D. S., et al. (2018). Dietary carbohydrates: Role in the pathogenesis of obesity and diabetes. The Lancet Diabetes & Endocrinology, 6(3), 242–255.  
  25. Westman, E. C., et al. (2008). The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control. Nutrition & Metabolism, 5, 36.  
  26. Athinarayanan, S. J., et al. (2019). Long-term effects of a novel continuous remote care intervention including nutritional ketosis for Type 2 diabetes. Frontiers in Endocrinology, 10, 348.  
  27. Mijatovic, J., et al. (2021). Low-carbohydrate diet in gestational diabetes: A randomized controlled trial. Diabetes Care, 44(7), 1543–1550.  
  28. Cunnane, S. C., et al. (2016). Can ketones compensate for deteriorating brain glucose uptake during aging? Annals of the New York Academy of Sciences, 1367(1), 12–20.  
  29. Holten, M. K., et al. (2004). Strength training increases insulin-mediated glucose uptake and insulin sensitivity. Diabetes, 53(5), 1369–1375.  
  30. Sutton, E. F., et al. (2018). Early time-restricted feeding improves insulin sensitivity in men with prediabetes. Cell Metabolism, 27(6), 1212–1221.  
  31. Hallberg, S. J., et al. (2018). Effectiveness and safety of a novel care model for the management of Type 2 diabetes at 1 year. Diabetes Therapy, 9(2), 583–612.  
  32. Boden, G., et al. (2005). Effect of a low-carbohydrate diet on appetite, blood glucose, and insulin resistance. Annals of Internal Medicine, 142(6), 403–411.  
  33. Spiegel, K., et al. (1999). Impact of sleep debt on metabolic and endocrine function. The Lancet, 354(9188), 1435–1439.  
  34. ADA. (2019). Public awareness of insulin’s role: Survey findings. American Diabetes Association Annual Report.
  35. Defeudis, G., et al. (2022). “Erectile dysfunction as a cardiovascular risk factor: Time to step up?” Andrology, 10(2), 221-231.  
  36. Shamloul, R., & Ghanem, H. (2013). “Erectile dysfunction.” The Lancet, 381(9861), 153-165.  
  37. Esposito, K., et al. (2005). “High proportions of erectile dysfunction in men with the metabolic syndrome.” Diabetes Care, 28(5), 1201-1203.  
  38. Maiorino, M. I., et al. (2014). “Insulin resistance and endothelial dysfunction in erectile dysfunction: The missing link?” Journal of Sexual Medicine, 11(12), 2799-2808.
  39. Walton, C.M., et al. (2019). “Improvement in Glycemic and Lipid Profiles in Type 2 Diabetics with a 90-day Ketogenic Diet”. J Diabetes Res, PMID: 31485454.

Related topics